Summary
Global Markets Directs, Dental Plaque - Pipeline Review, H1 2012, provides an overview of the Dental Plaque therapeutic pipeline. This report provides information on the therapeutic development for Dental Plaque, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Plaque. Dental Plaque - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Dental Plaque.
- A review of the Dental Plaque products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Table of contents:
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Esophagitis Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Esophagitis 11
Esophagitis
Therapeutics under Development by Companies 13
Esophagitis Therapeutics under Investigation by Universities/Institutes 16
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21
Esophagitis Therapeutics Products under Development by Companies 22
Esophagitis Therapeutics Products under Investigation by Universities/Institutes 23
Companies Involved in Esophagitis Therapeutics Development 24
Takeda Pharmaceutical Company Limited 24
XenoPort, Inc. 25
Novartis AG 26
Axcan Pharma Inc. 27
Cephalon, Inc. 28
Eisai Co., Ltd. 29
Santarus, Inc. 30
Wockhardt Limited 31
Shire Plc 32
iCo Therapeutics Inc. 33
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012PubId=pagenum=1
Erosive Oral Lichen Planus Pipeline Review, H1 2012
Pancreatic Cancer Pipeline Review, H1 2012
Metastatic Hormone Refractory Prostate Cancer Pipeline Review, H1 2012
Myasthenia Gravis Pipeline Review, H1 2012
Dental Plaque Pipeline Review, H1 2012
Esophagitis Pipeline Review, H1 2012
Retinitis Pigmentosa (Retinitis) Pipeline Review, H1 2012
Cellulite Pipeline Review, H1 2012
HIV Pain Pipeline Review, H1 2012
Tropical Spastic Paraparesis Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and HealthcarePubId=pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
